MedPath

Sodium phosphate, monobasic

Generic Name
Sodium phosphate, monobasic
Brand Names
As 3, Cpda-1 Blood Collection System, Glycerolyte 57, Intersol, Ionosol-MB, K-phos Neutral, K-phos No 2, Leukotrap, Osmoprep, Phosphasal, Rejuvesol, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Ustell
Drug Type
Small Molecule
Chemical Formula
H2NaO4P
CAS Number
7558-80-7
Unique Ingredient Identifier
KH7I04HPUU

Overview

Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours.

Background

Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours.

Indication

Used to treat constipation or to clean the bowel before a colonoscopy .

Associated Conditions

  • Acid Base Imbalance
  • Acidosis
  • Burns
  • Constipation
  • Dehydration
  • Diarrhea
  • Drug Poisoning
  • Electrolyte imbalance
  • Hypophosphatemia
  • Mild, moderate Metabolic Acidosis

FDA Approved Products

UROGESIC BLUE
Manufacturer:EDWARDS PHARMACEUTICALS, INC.
Route:ORAL
Strength:40.8 mg in 1 1
Approved: 2023/01/10
NDC:0485-0151
UROGESIC BLUE
Manufacturer:EDWARDS PHARMACEUTICALS, INC.
Route:ORAL
Strength:40.8 mg in 1 1
Approved: 2023/01/13
NDC:0485-0151
Saline Enema
Manufacturer:Dynarex Corporation
Route:RECTAL
Strength:19 g in 118 mL
Approved: 2025/05/14
NDC:67777-402

Singapore Approved Products

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Manufacturer:FRESENIUS KABI NORGE AS
Form:INJECTION
Strength:53.7 mcg/ml
Online:Yes
Approved: 1996/09/04
Approval:SIN08899P
ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION
Manufacturer:Fresenius Kabi Norge AS
Form:INFUSION, SOLUTION CONCENTRATE
Strength:102.3 mcg/ml
Online:Yes
Approved: 2017/07/24
Approval:SIN15302P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath